I. Vachier (Montpellier, France), B. Oliver (Sydney, Australia)
Dissociation between clinical trial inclusion and exclusion criteria for trials in severe asthma and the reality of the patient population
T. Brown, H. Rupani, C. Barber, S. Elliot, K. Gove, L. Lau, L. Hewitt, E. Ray, E. Aitken, S. Kerley, R. Kurukulaaratchy, C. Grainge, R. Djukanovic, A. Chauhan, P. Howarth (Portsmouth, Southampton, United Kingdom)
|  |
Gene set variation analysis of mRNA expression in bronchial biopsies from the U-BIOPRED asthma study
S. Pavlidis, A. Rowe, I. Adcock, K. Russell, I. Pandis, Y. K. Guo, B. DMeuldere, D. Lefaudeux, C. Auffray, R. Djukanovic, P. Howarth, F. Chung, M. Loza, N. Rao, F. Baribaud (High Wycombe, Buckinghamshire, London, Southampton, United Kingdom; Lyon, France; Springhouse, United States Of America)
|  |
Abediterol, a novel long-acting inhaled beta2-agonist, has a fast association rate and long residence time at human beta2 receptors
M. Miralpeix, M. Letosa, M. Aparici, C. Puig, A. Gavaldà, D. Vilella, I. Ramos (Barcelona, Spain)
| |
Pharmacokinetics (PK), safety and tolerability of abediterol and mometasone furoate fixed- and free-dose combinations in healthy subjects
E. Jimenez, E. DeNoia, S. Ruiz, B. Seoane, E. Massana, G. De Miquel, C. Astbury (Barcelona, Spain; San Antonio, United States Of America)
| |
Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients
J. De Backer, C. V. Holsbeke, W. Vos, S. Vinchurkar, J. Rebello, M. Mangale, W. De Backer (Kontich, Wilrijkstraat 10, 2650, Belgium; Mumbai, India)
| |
Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function
I. Heijink, M. Jonker, N. Ten Hacken, E. Telenga, D. Postma, M. Van den Berge (Groningen, Netherlands)
| |
The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway
A. Durham, E. Jazrawi, J. A. Rhodes, C. Williams, I. Kilty, P. Barnes, K. F. Chung, I. Adcock (London, United Kingdom; Cambridge, United States Of America)
| |
Anti-inflammatory effects of targeted lung denervation in patients with COPD
L. Kistemaker, D. J. Slebos, H. Meurs, H. Kerstjens, R. Gosens (Groningen, Netherlands)
| |
Long-lasting interaction study between RPL554 and glycopyrronium bromide on human isolated bronchi
L. Calzetta, M. Cazzola, C. Page, P. Rogliani, F. Facciolo, M. G. Matera (Rome, Naples, Italy; London, United Kingdom)
| |
Pharmacological activities of roflumilast N-oxide, dexamethasone and formoterol in human neutrophils from healthy non-smokers and COPD patients
J. Milara, J. Lluch, A. Serrano, J. Freire, M. Qian, M. Alonso-Galicia, C. Sanz, R. Guijarro, J. Cortijo (Valencia, Spain; Jersey City, United States Of America)
| |
Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition
S. Canisius, K. Nocker, G. Scheuch, T. Hofmann (Gemünden, Germany)
| |
Interaction between RPL554 and glycopyrronium bromide in small human airways
L. Calzetta, M. Cazzola, C. Page, P. Rogliani, F. Facciolo, M. G. Matera (Rome, Naples, Italy; London, United Kingdom)
| |
Interaction between aclidinium bromide and formoterol fumarate in small human airways
M. Cazzola, L. Calzetta, C. P. Page, P. Rogliani, F. Facciolo, A. Gavaldà, M. G. Matera (Rome, Naples, Italy; London, United Kingdom; Barcelona, Spain)
| |
Development of a lung slice methodology to study the mechanisms of lung uptake and lysosomal trapping
E. Bäckström, A. Lundqvist, P. Svanberg, E. Boger, P. Ewing, M. Hammarlund-Udenaes, M. Fridén (Uppsala, Mölndal, Sweden)
| |
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model)
K. Hajipouran Benam, R. Villenave, C. Lucchesi, M. Mazur, G. Hamilton, D. Ingber (Boston, United States Of America)
| |
Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstriction
T. Nabe, T. Sekioka, M. Kadode, M. Fujii, T. Abe, M. Horiba, S. Kohno, K. Kawabata (Osaka, Kyoto, Gifu, Japan)
| |
miRNA-145 & SMAD3 expression in patients with COPD
L O’Leary, B. Tildy, I. Papazoglou, I.M. Adcock, K.F. Chung, M. Perry (London, United Kingdom)
| |
Decametoxine efficiency in the treatment of infectious exacerbation of asthma
M. Gumeniuk, S. Panchuk (Kyiv, Ukraine)
| |